Eagle Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,506,284	Closed	-$22.9M	–	683
2019 Q4	$22.9M	Buy	4,506,284 +2,190	+0%	+$11.6K	0.11%	222
2019 Q3	$22.8M	Buy	4,504,094 +4,386	+0.1%	+$21.9K	0.12%	220
2019 Q2	$27.8M	Sell	4,499,708 -8,722	-0.2%	-$42.1K	0.14%	210
2019 Q1	$20.9M	Buy	4,508,430 +13,065	+0.3%	+$59.1K	0.11%	222
2018 Q4	$18.9M	Buy	4,495,365 +50,692	+1%	+$258K	0.12%	217
2018 Q3	$27.9M	Sell	4,444,673 -16,809	-0.4%	-$129K	0.13%	221
2018 Q2	$35.9M	Sell	4,461,482 -9,356	-0.2%	-$71.4K	0.19%	189
2018 Q1	$33.4M	Buy	4,470,838 +310,078	+7%	+$2.06M	0.18%	186
2017 Q4	$24.6M	Sell	4,160,760 -6,159	-0.1%	-$37.4K	0.14%	224
2017 Q3	$32.2M	Buy	4,166,919 +154,553	+4%	+$982K	0.18%	191
2017 Q2	$27.2M	Buy	4,012,366 +1,352,245	+51%	+$9.98M	0.16%	205
2017 Q1	$25.1M	Sell	2,660,121 -5,143	-0.2%	-$51.3K	0.16%	194
2016 Q4	$23M	Buy	+2,665,264	New	+$19.7M	0.15%	201